Judah Frommer
Stock Analyst at Morgan Stanley
(5)
Main Sectors:
Top Industries:
44 Stocks
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
ABVX Abivax | Maintains: Overweight | 71 101 | 82.84 | 21.92% | 3 | Sep 12, 2025 | |
TRVI Trevi Therapeutics | Initiates Coverage On: Overweight | 18 | 8.77 | 105.25% | 1 | Aug 21, 2025 | |
APLS Apellis Pharmaceutic... | Maintains: Equal-Weight | 25 26 | 22.37 | 16.23% | 2 | Jul 2, 2025 | |
BPMC Blueprint Medicines | Maintains: Equal-Weight | 102 129 | n/a | n/a | 2 | Jun 5, 2025 | |
CLDX Celldex Therapeutics | Maintains: Overweight | 46 43 | 26.14 | 64.5% | 2 | May 9, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 22 24 | 9.65 | 148.7% | 2 | Mar 14, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | 31 22 | 33.78 | -34.87% | 3 | Feb 14, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 8 6 | 8.39 | -28.49% | 2 | Jan 13, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 81 106 | 79.75 | 32.92% | 2 | Nov 6, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 35 | 11.71 | 198.89% | 1 | Oct 8, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 13 | 2.09 | 522.01% | 1 | Apr 4, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Equal-Weight | 3 | 2.49 | 20.48% | 1 | Mar 7, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 40 | 2.47 | 1519.43% | 8 | Aug 14, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 4 | n/a | n/a | 3 | Aug 11, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 13 | 1.42 | 815.49% | 5 | Aug 9, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 30 | 42.95 | -30.15% | 8 | Aug 9, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 23 | 24.14 | -4.72% | 5 | Aug 8, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 50 | 58.99 | -15.24% | 9 | Jul 20, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 141 | 18.36 | 667.97% | 13 | Jun 23, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 156 | n/a | n/a | 5 | May 16, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 9 | 5.27 | 70.78% | 5 | May 12, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 175 138 | n/a | n/a | 6 | May 10, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 21 22 | 28.5 | -22.81% | 2 | Apr 3, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 8 7 | 5.54 | 26.35% | 3 | Mar 31, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 7 1 | n/a | n/a | 4 | Mar 20, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 11 8 | 8.84 | -9.5% | 5 | Mar 10, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 46 | 32.68 | 40.76% | 5 | Mar 7, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Neutral | 7 7 | 2.65 | 164.15% | 6 | Mar 7, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 51 55 | 54.31 | 1.27% | 3 | Feb 28, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 46 | 137.03 | -66.43% | 1 | Feb 24, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underperform | 4 4 | n/a | n/a | 1 | May 11, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 14 10 | n/a | n/a | 2 | Oct 12, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 47 49 | 104.33 | -53.03% | 4 | Nov 5, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 328 370 | 915.95 | -59.6% | 2 | Oct 6, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 24 31 | 76.59 | -59.52% | 6 | Sep 21, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 65 76 | 81.96 | -7.27% | 8 | Sep 21, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Neutral | 182 | 102.08 | 78.29% | 6 | Aug 6, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Outperform | 107 | 95.06 | 12.56% | 13 | Aug 6, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 90 95 | 132.4 | -28.25% | 10 | Jul 22, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 18 | 17.55 | 2.56% | 1 | Jul 21, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 93 116 | 154.76 | -25.05% | 12 | Jun 10, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 31 38 | 93.1 | -59.18% | 4 | May 22, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 18 22 | 109.88 | -79.98% | 1 | May 6, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 33 35 | 65.46 | -46.53% | 9 | Apr 29, 2020 |